Margot Jehle’s Post

🚀 How Our Financial Support Program Is Empowering Breaz to Revolutionize #Lung Health 🌍💡 ⏩ Check out our #16 BioMan4R2 Success Story! We are proud to highlight the amazing impact our financial support program has had on Breaz, a startup making lung health diagnostics accessible to everyone with their cutting-edge, simple, and accurate medical device. 💼 What #Breaz is doing:  Breaz's digital-hardware hybrid solution guides healthcare professionals in diagnosing and treating respiratory diseases like COPD, even in resource-limited settings such as primary care centers. 🌟 With our support, Breaz is: ✅ Exploring regulatory approval paths for their respiratory diagnostic device in the European Union, streamlining their time to market. ✅Investigating access routes under #FDA regulation in the #USA and confirming their approach with relevant authorities. 🏥 Why this matters: Supporting startups like #Breaz, especially in the medical device sector, is crucial. This industry faces unique challenges, including stringent regulations and complex approval processes. This financial support helps startups navigate these hurdles, speeding up innovation that ultimately benefits patients worldwide. 🙌 We’re thrilled to see #Breaz thrive and make a lasting impact on lung health with our financial backing! 🎉Congratulations on your achievements! 🎉 James Hugall , Alfons Porro i Martorell #StartUp #InnovationInHealth #MedicalDevices #Patients #Healthcare #Innovation #COPD #LungHealth #TechForGood #EURegulation #PrimaryCare #biomanufacturing #bioproduction #BioMan #Europe #EuropeanProjects

🎆 We're thrilled to announce that Lenexa Medical has secured a $50,000 MedTech Market Growth Program Grant from LaunchVic and Department of Jobs, Skills, Industry and Regions This grant will help us in manufacturing more of our Victorian-made LenexaCARE care system; and providing personalised aid to additional healthcare facilities in the prevention of pressure injuries (PIs). Did you know? A 2022 study estimated that PIs cost Australian hospitals $9.11 billion with many being hospital-acquired injuries. The LenexaCARE System can help change this through active monitoring and prevention strategies to keep PIs under control, keeping patients from further pain as well as saving Australian hospitals billions of dollars. For more information, visit: https://lnkd.in/gYae2gUY 🚀 #LenexaMedical #LenexaCARE #MedTechMarketGrowthProgram #MedTech #HealthTech #LaunchVic #MadeInVictoria #PressureInjuryPrevention #InnovationInHealthcare

📢 [#Supporter2024 MedFIT] 🌟 Institut TransMedTech de Montréal has joined the MedFIT 2024 partners! Here is some important information about this partner! 🔍 The mission & The Vision of Institut TransMedTech de Montréal are: 🙌 to #SUPPORT, medical technologies, for important diseases, and that meet the needs of the users and the healthcare community 🚀 to #FACILITATE and catalyze their development and implementation in the healthcare system. to #TRAIN the next generation of medtech leaders and to support the industry and the innovation community. 📈 and to #HAVE a significant impact on health, the medtech industry, the training of tomorrow's highly qualified professionals and society. 📌 Institut TransMedTech de Montréal have a Transdisciplinary co-development based on : the dynamics of user needs and added value for the healthcare system and involving all stakeholders early in the process. 🗝 Keyfigures of Institut TransMedTech: #agility #connectivity #proactivity // Unique Living Lab approach // #Entrepreneurship, patient autonomy and socio-economic impact 📤 If you wish to join them as a partner MedFIT Event, contact: Célestine Fillon - Yingjie WENG

#NurMitMedTech - MedTech is part of the solution! #Thankyou: BVMed - Bundesverband Medizintechnologie 👉 Essential for Health and Quality of Life Medical technologies play a crucial role in human health and well-being. MedTech is also a flagship sector of the German economy and a key industry for Germany’s future. 👉 Innovation Driver The MedTech sector fuels innovation, with companies investing an average of 9% of revenue in research and development. 👉 Job Creator Over 265,000 people are employed in MedTech companies across Germany. The sector offers 13,000 training positions in future-oriented technologies. 👉 Predominantly SMEs and Family-Owned Companies Around 93% of the MedTech sector consists of medium-sized businesses and family-owned enterprises. Research and production are largely based within Germany. 👉 Global Export Leader Germany’s MedTech sector has a 68% export rate. Annual revenue exceeds €40 billion, and including small enterprises, it surpasses €55 billion. Germany ranks first in Europe and second worldwide, following the United States. #Medtech #Germany #strong #NurMitMedTech #RegulatoryAffairs #MDR #IVDR #CDMO

🔎 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮 #𝗗𝗧𝘅 𝗼𝗿 #𝗿𝗲𝗺𝗼𝘁𝗲𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝘀𝘁𝗮𝗿𝘁𝘂𝗽 𝘄𝗮𝗻𝘁𝗶𝗻𝗴 𝘁𝗼 𝗴𝗲𝘁 𝗿𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗙𝗿𝗮𝗻𝗰𝗲? 🗓 Join us this 10th and 11th of June for a unique workshop with the Délégation au numérique en santé (DNS), Haute Autorité de Santé, France Biotech, and Nextep Health to deeply understand #PECAN and other reimbursement paths, including legislation, regulation, and its key stakeholders. Our deep dive will break down how digital medical products can use their clinical data, review their commercialization strategy, and prepare to succeed in the French healthcare market. Our speakers will provide guidance and advice to understand regulatory frameworks, review and strengthen clinical evidence, and how to be fit for PECAN and other reimbursement paths. Join us to meet: 🎤 Corinne Collignon: As the head of the digital health mission department (Haute Autorité de Santé), she has worked for many years in the medical device evaluation department and will provide her experience around the HAS' expectations (clinical evidence, validation, and evaluation of medical devices). 🎤 Pascal Sellier: As the Vice-Chairman of the National Commission for the Evaluation of Medical Devices and Health Technologies at Haute Autorité de Santé, he represents the voice of patients and users in the French healthcare system. 🎤 Stephane Tholander: Currently he is the coordinator of the digital health commission and vice-president of France Biotech. As a serial entrepreneur and Co-Founder/co-CEO of Agora Health and AppThera, he is focused on innovation in healthcare and facilitating the acceleration and adoption of digital medical devices from all angles. 🎤 Vincent Vercamer: With extensive expertise in regulation and market access, he is currently the project director at the French Ministerial Delegation for Digital Health (DNS/Ministère de la Santé) and works closely with the Agence du numérique en santé, responsible for issues relating to #marketaccess and #PECAN. Additionally, he coordinates the G_NIUS platform, supporting innovators in preparing for their reimbursement applications. 🎤 Helene Viatge: With extensive expertise in medical device development and commercialization in France and Europe and founder of AppThera, a clinician platform supporting the prescription of digital therapeutics and enabling patient access. ✅ 𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘯𝘰𝘸 𝘣𝘺 𝘤𝘰𝘯𝘵𝘢𝘤𝘵𝘪𝘯𝘨 𝘰𝘶𝘳 𝘵𝘦𝘢𝘮 𝘰𝘳 𝘴𝘦𝘯𝘥𝘪𝘯𝘨 𝘶𝘴 𝘢 𝘮𝘦𝘴𝘴𝘢𝘨𝘦 𝘷𝘪𝘢 𝘓𝘪𝘯𝘬𝘦𝘥𝘪𝘯 𝘵𝘰 𝘴𝘦𝘤𝘶𝘳𝘦 𝘺𝘰𝘶𝘳 𝘴𝘱𝘰𝘵! #Healthcare #Startups #PECAN #MarketEntry #Regulation #ClinicalEvidence #Workshop #Networking

🚨 Medical Technology Ireland Expo & Conference: A Hub for MedTech Innovation Attention #MedTech professionals! The upcoming Medical Technology Ireland Expo & Conference is set to be a major gathering of industry leaders, innovators, and experts in the #medicaldevice design and #manufacturing space. As one of Europe’s largest and fastest-growing events, it provides an unparalleled opportunity to explore the latest advancements and trends shaping the MedTech sector. #MedicalTechnology #IrelandInnovation #HealthcareTransformation Go check the post below 👇

Breaking news: US MedTech startups are looking south for innovation. 🌎 Arissa Medical just completed their 3rd cohort of patients in Chile for their groundbreaking Syntra device. Why Latin America? • Faster patient recruitment • Lower costs • High-quality healthcare systems • Experienced investigators This trend is reshaping the global MedTech landscape. As someone who's been bridging US and LatAm MedTech for years, I'm excited to see this shift. What other benefits do you see in this approach? #MedTechInnovation #ClinicalTrials #LatAmHealthcare #bioaccess

A new study demonstrated that Extended-release buprenorphine (XR-Bup) was associated with a reduction in ED use six months after initiation, indicating a potential increase in patient adherence and a reduction in healthcare system costs overall (https://lnkd.in/e5XpSMnZ). Incremental or sustaining drug innovations like XR-Bup can disrupt the market and create enormous value for stakeholders. Ideas don't always have to be disruptive to create impact. Whether you have an idea for an incremental or a disruptive innovation, our program can help you identify how to move it into the market. Apply today - https://lnkd.in/e9FiW56p

Exciting news in the world of health tech! OneTwenty AG, a Zurich-based MedTech Europe startup, just secured its first major financing round! Here’s why it’s a big deal for everyone, especially if you care about innovative diabetes care. 1️⃣ Platform Capital: Pioneering AI-Driven Supply Chain Innovations with www.Wisefy.ai They're enhancing diabetes devices like insulin pumps and sensors with AI algorithms, making diabetes management smarter and more responsive to individual needs. 2️⃣ bioX® Technology: This isn't just another app. It’s a groundbreaking technology that learns from over 4.4 million CGM hours to provide personalized care that adapts to daily life and stress. 3️⃣ Strategic Thinking Growth: With funds from heavy hitters like Dieter von Holtzbrinck Ventures, OneTwenty is set to revolutionize diabetes care, building a future where managing diabetes is less of a burden. With this leap, OneTwenty isn’t just another company; they're potential game-changers in making life better for millions with diabetes. Kudos to the team at OneTwenty for this amazing milestone! P.S. Know anyone who’s managing diabetes? What do they look for in care technology? #HealthTech #DiabetesCare #Innovation #Mondayfunding Check them out here: https://lnkd.in/dxacwAF7

Great news on Q1 ‘24 MedTech Funding! “Financially, the funding climate in MedTech has increased by a significant amount in 2024 to date. In 2023, the entire year funding total was captured in our annual MedTech funding report and equated to $17.95 billion dollars of investments. The shocking low funding total was the result of the COVID-19 pandemic surge of funding in the peak pandemic years of 2021 - 2022 followed by the drastic dip in the following 2023 year, known as the “COVID Cliff”. This total made up approximately 11% of the MedTech market in reference to the number of MedTech companies. In contrast to last year, Q1 2024 alone saw a total of $11.04 billion dollars worth of investments received by MedTech companies around the globe excluding revenue dollars. The numbers suggest that the market is picking back up in a big way. However, looking at the M&A volume and clinical pipeline numbers between Q1 2023 and Q1 2024, we can have a more accurate look at how funding is a lagging indicator to how a market will perform in the current year.” MedTech Innovator MedTech World LSI MedTech Strategist MedTech Startup